Parallax Volatility Advisers
CVS icon

Parallax Volatility Advisers’s CVS Health CVS Stock Holding History

Parallax Volatility Advisers’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.5M Sell
45,200
-250,300
-85% -$19.3M 0.01% 665
2025
Q4 		$23.5M Buy
295,500
+105,900
+56% +$8.35M 0.05% 270
2025
Q3 		$14.3M Sell
189,600
-127,400
-40% -$8.73M 0.02% 361
2025
Q2 		$21.9M Sell
317,000
-32,900
-9% -$2.16M 0.05% 255
2025
Q1 		$23.7M Buy
349,900
+38,700
+12% +$2.32M 0.06% 234
2024
Q4 		$14M Buy
311,200
+275,800
+779% +$15.5M 0.03% 454
2024
Q3 		$2.23M Sell
35,400
-236,100
-87% -$13.8M ﹤0.01% 1092
2024
Q2 		$16M Buy
271,500
+82,700
+44% +$5.17M 0.03% 342
2024
Q1 		$15.1M Sell
188,800
-1,020,900
-84% -$78M 0.03% 383
2023
Q4 		$95.5M Buy
1,209,700
+573,600
+90% +$40.8M 0.2% 83
2023
Q3 		$44.4M Buy
636,100
+502,200
+375% +$35.6M 0.1% 168
2023
Q2 		$9.26M Sell
133,900
-409,100
-75% -$29.1M 0.02% 563
2023
Q1 		$40.4M Sell
543,000
-745,800
-58% -$62.5M 0.08% 234
2022
Q4 		$120M Sell
1,288,800
-40,800
-3% -$3.94M 0.19% 104
2022
Q3 		$127M Buy
1,329,600
+664,200
+100% +$65.7M 0.2% 83
2022
Q2 		$61.7M Sell
665,400
-57,900
-8% -$5.65M 0.06% 230
2022
Q1 		$73.2M Buy
+723,300
New +$76M 0.04% 191
2020
Q4 		– Sell
-1,785,000
Closed -$104M – 2713
2020
Q3 		$104M Buy
1,785,000
+402,700
+29% +$25.1M 0.08% 220
2020
Q2 		$89.8M Sell
1,382,300
-685,700
-33% -$43.2M 0.11% 153
2020
Q1 		$123M Buy
2,068,000
+140,800
+7% +$9.4M 0.16% 85
2019
Q4 		$143M Buy
1,927,200
+166,500
+9% +$11.7M 0.17% 84
2019
Q3 		$111M Buy
1,760,700
+1,212,600
+221% +$71.9M 0.12% 99
2019
Q2 		$29.9M Sell
548,100
-921,700
-63% -$49.6M 0.03% 263
2019
Q1 		$79.3M Sell
1,469,800
-163,666
-10% -$10.1M 0.09% 102
2018
Q4 		$107M Buy
1,633,466
+1,366,966
+513% +$102M 0.14% 112
2018
Q3 		$21M Sell
266,500
-90,500
-25% -$6.47M 0.03% 282
2018
Q2 		$23M Buy
+357,000
New +$23.5M 0.03% 240
2018
Q1 		– Sell
-856,600
Closed -$62.1M – 2537
2017
Q4 		$62.1M Buy
856,600
+6,300
+0.7% +$458K 0.08% 112
2017
Q3 		$69.1M Sell
850,300
-119,900
-12% -$9.48M 0.11% 102
2017
Q2 		$78.1M Sell
970,200
-2,801,600
-74% -$221M 0.15% 89
2017
Q1 		$296M Buy
3,771,800
+2,734,300
+264% +$218M 0.61% 18
2016
Q4 		$81.9M Buy
1,037,500
+914,500
+743% +$74M 0.16% 92
2016
Q3 		$10.9M Sell
123,000
-8,500
-6% -$802K 0.02% 412
2016
Q2 		$12.6M Sell
131,500
-329,200
-71% -$32.8M 0.02% 381
2016
Q1 		$47.8M Buy
460,700
+149,600
+48% +$14.5M 0.1% 119
2015
Q4 		$30.4M Buy
311,100
+193,300
+164% +$18.9M 0.06% 200
2015
Q3 		$11.4M Buy
117,800
+55,700
+90% +$5.86M 0.03% 399
2015
Q2 		$6.52M Sell
62,100
-172,300
-74% -$17.6M 0.01% 632
2015
Q1 		$24.2M Buy
234,400
+133,100
+131% +$13.5M 0.06% 269
2014
Q4 		$9.76M Buy
101,300
+81,400
+409% +$7.17M 0.03% 475
2014
Q3 		$1.59M Buy
19,900
+13,100
+193% +$1.03M 0.01% 1219
2014
Q2 		$513K Sell
6,800
-4,500
-40% -$340K ﹤0.01% 1373
2014
Q1 		$844K Sell
11,300
-23,100
-67% -$1.63M 0.01% 824
2013
Q4 		$2.46M Sell
34,400
-1,700
-5% -$109K 0.01% 611
2013
Q3 		$2.05M Buy
36,100
+5,000
+16% +$298K 0.01% 525
2013
Q2 		$1.78M Buy
+31,100
New +$1.8M 0.01% 610

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parallax Volatility Advisers's CVS Position: Q1 2026 in Review

Parallax Volatility Advisers increased its CVS Health (CVS) stake by 1,675% in Q1 2026, buying an estimated $8.14M and bringing the position to 112,013 shares worth $8.67M. The position accounts for 0.02% of the portfolio, ranked #446.

Parallax Volatility Advisers first reported a position in CVS in Q2 2013 and has held it in 33 quarters since. The position peaked at $43.7M in Q1 2020. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Parallax Volatility Advisers held 112,013 shares of CVS Health worth $8.67M as of Q1 2026.
  • Parallax Volatility Advisers bought 105,704 CVS Health shares in Q1 2026, an estimated $8.14M.
  • CVS Health made up 0.02% of Parallax Volatility Advisers's portfolio in Q1 2026, its #446 holding.
  • Parallax Volatility Advisers first reported a position in CVS Health in Q2 2013 and has held it in 33 quarters since.
  • Parallax Volatility Advisers's CVS Health position peaked at $43.7M in Q1 2020.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.